Investigational Drug Information for Bimagrumab
✉ Email this page to a colleague
What is the drug development status for Bimagrumab?
Bimagrumab is an investigational drug.
There have been 8 clinical trials for Bimagrumab.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 2nd 2015.
The most common disease conditions in clinical trials are Myositis, Inclusion Body, Myositis, and Sarcopenia. The leading clinical trial sponsors are Novartis Pharmaceuticals, Versanis Bio, Inc., and [disabled in preview].
There are two US patents protecting this investigational drug and eighteen international patents.
Summary for Bimagrumab
| US Patents | 2 |
| International Patents | 18 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-11-02) |
| Vendors | 0 |
Recent Clinical Trials for Bimagrumab
| Title | Sponsor | Phase |
|---|---|---|
| Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese | Versanis Bio, Inc. | Phase 2 |
| Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes | Novartis Pharmaceuticals | Phase 2 |
| An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 | Novartis Pharmaceuticals | Phase 3 |
Clinical Trial Summary for Bimagrumab
Top disease conditions for Bimagrumab
Top clinical trial sponsors for Bimagrumab
US Patents for Bimagrumab
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bimagrumab | ⤷ Try a Trial | Binding-triggered transcriptional switches and methods of use thereof | The Regents of the University of California (Oakland, CA) | ⤷ Try a Trial |
| Bimagrumab | ⤷ Try a Trial | Administration of bimagrumab for improving muscle mass and function after hip fracture surgery | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bimagrumab
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bimagrumab | Australia | AU2015249396 | 2034-04-24 | ⤷ Try a Trial |
| Bimagrumab | Australia | AU2018200537 | 2034-04-24 | ⤷ Try a Trial |
| Bimagrumab | Brazil | BR112016023979 | 2034-04-24 | ⤷ Try a Trial |
| Bimagrumab | Canada | CA2944842 | 2034-04-24 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
